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Abstract  
 
 
The present study was carried out to isolate and identify the different 
type of  Bacillus ssp from different sources.And to tested their metabolites as 
bactericidal to Staphylococci 
Thirty two Gram positive bacilli were isolated from different sources. 
The main source was contaminants in bacteriological cultures. 
The isolates were screened for their production of metabolites against 
Staphylococcus (Staphylococcus aureus, Staphylococcus epidermidis and 
Staphylococcus saprophytycus). 
Three of these isolates were positive for production of metabolites that 
completely inhibited Staphylococcus growth .The three positive isolates 
were Bacillus cereus,  Bacillus lichniformis and Bacillus subtilis  
The metabolites were isolated and partially purified from these 
species in order to study their chemical and physical properties. The result of 
chemical and physical properties of the active  metabolites filtrates revealed 
the presence of an extracellular  thermosensetive (the metabolite degrading 
by high temperature ) ,but these metabolites could be kept at room 
temperature for long time . 
In order to establish the inhibitory activity unit different metabolite  
filtrates dilutions were tested against Staphylococcus spp. The inhibitory 
activity unit which is higher dilution of metabolite filtrate that inhibits in 
vitro the Staphylococcus growth Was 1x10-1 
 viii
From plate assay to establish the bacteriostatic or bactericidal activity 
of metabolite filtrate, the result revealed that the metabolites have 
bactericidal effect against staphylococcus spp. 
The metabolite filtrate stability test against enzymes revealed that the 
metabolite filtrates were denatured by protease enzyme          
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   اﷲ اﻟﺮﺣﻤﻦ اﻟﺮﺣﻴﻢﺑﺴﻢ
   اﻷﻃﺮوﺣﺔﻣﻠﺨﺺ    
 ﻣѧﺼﺎدر اﻟﻌѧﺼﻴﺎت اﻟﺒﺎﺳѧﻴﻠﻴﺔ اﻟﻤﻮﺟﺒѧﻪ ﻟѧﺼﺒﻐﺔ ﺟѧﺮام، ﻣѧﻦ ﻣѧﻦ ﻋѧﺰل إﺛﻨѧﺎن وﺛﻼﺛѧﻮن  ﺗѧﻢ
ﺛﻼﺛѧѧﺔ ﻣѧѧﻦ هѧѧﺬﻩ اﻟﻌѧѧﺼﻴﺎت . ﻣﺨﺘﻠﻔѧѧﺔ، أهѧѧﻢ هѧѧﺬة اﻟﻤѧѧﺼﺎدر آѧѧﺎن اﻟﻤѧѧﺰارع اﻟﺒﺎآﺘﺮﻳﻮﻟﻮﺟﻴѧѧﺔ 
ﻘﻮدﻳѧﺔ  ﻟﻬﺎ اﻟﻤﻘﺪرة ﻋﻠﻲ إﺣﺒﺎط ﻧﻤѧﻮ ﺑﻌѧﺾ أﻧѧﻮاع اﻟﻤﻜѧﻮرات اﻟﻌﻨ آﺎن اﻟﻤﻌﺰوﻟﻪ اﻟﺒﺎﺳﻴﻠﻴﺔ
   اﻟﻌﻨﻘﻮدﻳﺔ اﻟﺬهﺒﻴﺔ واﻟﻤﻜﻮرات اﻟﺒﺸﺮﻳﺔ آﺎﻟﻤﻜﻮرات
 اﻟﻘѧѧﺪرة ﻋﻠѧѧﻲ إﺣﺒѧѧﺎط ﻧﻤѧѧﻮ اﻟﻤﻜѧѧﻮرات اﻟﻌﻨﻘﻮدﻳѧѧﺔ هѧѧﻲ ﻟﻬѧѧﺎ اﻟﺒﺎﺳѧѧﻴﻠﻴﺔ اﻟﺘѧѧﻲ آѧѧﺎن اﻟﻌѧѧﺼﻴﺎت
 ﻟﻴﺸﻨﻴﻔﻮرﻣﺲ ﺛﻢ ﺗﻢ ﻋﺰل هﺬﻩ اﻟﻤﻮاد واﻟﺒﺎﺳﻴﻠﺲ ﺳﺒﺘﻠﺲ  واﻟﺒﺎﺳﻴﻠﻲاﻟﺒﺎﺳﻴﻠﺲ ﺳﻴﺮس  
 ﺑﻌѧѧﺾ ﻟﺪراﺳѧѧﺔآѧѧﻮرة   ﻣѧѧﻦ اﻟﻌѧѧﺼﻴﺎت اﻟﺒﺎﺳѧѧﻴﻠﻴﺔ اﻟﻤﺰ اﻟﺒﺎﺳѧѧﻴﻠﻴﺔاﻟﺘѧѧﻲ ﺗﻔﺮزهѧѧﺎ اﻟﻌѧѧﺼﻴﺎت 
 اﻟﻤѧѧﺎء وﻓѧѧﻲ ﻓѧѧﻲوﺗﺒѧѧﻴﻦ أن هѧѧﺬﻩ اﻟﻤѧѧﻮاد هѧѧﻲ ذاﺋﺒѧѧﺔ . ﺧﻮاﺻѧѧﻬﺎ اﻟﻜﻴﻤﻴﺎﺋﻴѧѧﺔ واﻟﻔﻴﺰﻳﺎﺋﻴѧѧﺔ
 آﻤﺎ أن اﻧѧﺰﻳﻢ ﻟﻠﺒﻜﺘﺮﻳﺎاﻟﻤﻴﺜﺎﻧﻮل آﻤﺎ أﻧﻬﺎ ﺣﺴﺎﺳﺔ ﻟﻠﺤﺮارﻩ وﺗﺒﻴﻦ أﻳﻀًﺎ أن ﻟﻬﺎ ﺗﺄﺛﻴﺮ ﻗﺎﺗﻞ 
   .   ﻋﻠﻲ ﻧﻔﻜﻴﻚ وﺗﺤﻠﻴﻞ هﺬﻩ اﻟﻤﻮادﻳﻌﻤﻞ Kﺑﺮوﺗﻴﻨﻴﺰ 
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The objectives of this work were:-  
 
1- Isolation and identification of different species of the genus Bacillus. 
2- Studies the bactericidal effect  of Bacillus metabolites  on Staphylococcus  
spp. 
3- Study of physical and chemical properties of these metabolites. 
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Introduction 
 
The use of microorganisms for biological purposes has become an 
effective alternative to control plant and animal pathogens. 
Bacillus are well known as bacterioin producer. However there is a 
direct relationship between the growth condition (limitation in nutrition) and 
capacity of production of these substances. The biological control of plant and 
animal pathogens is of paramount importance nowadays, since the 
conventional use of chemical treatment has been seriously questioned because 
of environmental and human hazards. 
There is direct relation between production of these active metabolites 
from Bacillus spp and sporulation of the Bacillus cell. The multiplicity of 
biologically active substances excreted by spore former into their culture 
medium is well known, but remain unexplained . In bacilli, which will be 
considered first, these are mainly antibiotics and exoenzymes , in clostridia  
they  include toxins . This active extracellular products include beside 
antibiotics  protease which is produced by Bacillus subtilis ,Bacillus 
licheniformis and Bacillus cereus. It has strong proteolytic activity Also there 
is amylase Asingle exoenzyme α amylase is responsible for the amylotic 
activity. Two types of RNA degrading enzymes are found in culture filtrate  
,and wall lytic enzyme .So we have many extracellular products ,that may 
responsible for the inhibition of Staphylococcus spp :antibiotics and protease 
and RNA degrading enzymes and wall lytic enzyme and amylase 
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This research refers to isolation of metabolites with bactericidal effect from 
bacillus spp against staphylococcus and studying their chemical and physical 
properties. 
The objectives of this work were:- 
1- Isolation and identification of different species of the genus Bacillus. 
2- STUDY The bactericidal effect of Bacillus metabolites on Staphylococcus  
spp. 
3- Study of physical and chemical properties of these metabolites. 
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CHAPTER ONE 
LITERATURE REVIEW 
 
1.1The genus Bacillus  
The   organisms   which belong to the group of aerobic spore bearing 
bacilli are cylindrical , usually flagellated grow in chain and produce large 
colonies on solid media(Merchant and Packer,1967) .Practically all species 
liquefy gelatin .Only one species Bacillus anthracis is pathogenic(Merchant 
and Packer,1967). They are found in soil and decaying vegetation where they 
are most active in bringing about decomposition of organic substance 
particularly those change grouped together under term ammonification. They 
are, therefore, create an important in maintenance of soil fertility(Merchant 
and Packer,1967) .Because of resistance of spore to high temperature and 
desiccation these organisms are among those which frequently  contaminate 
culture media in laboratories. (Merchant and Packer,1967) .                                                   
The various species are differentiated from each other by size , shape 
and position of spores and tendency to chain formation ,mobility by 
differences in culture and physiologic characteristic ,and pathogenisity .Beside 
Bacillus anthracis a few of other species which have been known to produce 
pathogenic condition, Bacillus subtilis may cause panaophthalmitis (Merchant 
and Packer,1967).  
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Species of the genus Bacillus are mainly Gram-positive rods motile 
(some non motile forms occur) and non acid fast. They produce heat resistant 
spores under aerobic conditions (Gordon et al., 1973).  
Bacillus species are widely disturbed in the environment mainly because of 
their highly resistant endospores. In soil endospores of Bacillus anthracis 
prototype of the genus, can survive for more than 50 years, able to tolerate 
extremely adverse conditions such as desiccation and high temperatures 
(Quinn et al., 2002).  
1.1.2Classification and Identification of the genus Bacillus: 
The genus Bacillus, the type  genus of the family Bacillaceae, included more 
than 60 species (Sneath, 1986). Classification of the genus Bacillus was made 
on the basis of aerobic growth of spore forming rods (Smith et al., 1952).  
Generally the Bacillus species are identified by methods based on spore 
morphology and biochemical reactions. Molecular methods such as DNA 
homology (Skey et al., 1978 and Krych et al., 1980), pyrolysis gas 
chromatography and pyrolysis mass spectrometry (O'Donnell et al., 1980) 
were also used in the identification of Bacillus species.  
There is considerable evidence that Bacillus thuringiensis (Bt) and Bacillus 
sphericus (Bsph) should be considered a single species (Bauman et al., 1984). 
Many reports reviewed that classical biochemical and morphological methods 
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of classifying bacteria have consistently faled to distinguished Bacillus 
thuringiensis from Bacillus sphericus (Kampfer, 1991).  
1.1.3 Habitat 
Bacillus species are ubiquitous, inhibiting soil, water, and airborne dust 
(Schnepf et al, 1998). Thermophilic and psychrophilic members of the genus 
can grow at temperatures ranging between (5 - 58)Cْ and can flourish at 
extremes of acidity and alkalinity ranging from pH 2 - 10 (Gordon et al., 
1973). Therefore Bacillus species can be recovered from a wide variety of 
ecological niches. Some species may be part of the normal intestinal 
microflora of humans and other animals (Elmer et al., 1997).  
Most Bacillus species encountered in the laboratory are saprophytic 
contaminants or members of the normal flora (Smith et al., 1952).  
1.1.4Morphology and cultural characteristics  
The Bacillus cell ranges from 0.5 - 1.2µm length in diameter (Merchant et al., 
1967). Catalase is produced by most species and sporulation is not inhibit by 
most incubation temperatures, positive characteristics that aid in 
distinguishing genus Bacillus from bacteria that  can grow aerobically on 
nutrient medium at 37Cْ, although the optimal temperature for growth of these 
bacteria, termed mesophiles, is at 37Cْ. They can grow at temperatures ranging 
between20-45Cْ. Those with an optimal incubation temperature of 15Cْ, are 
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termed psychrophiles and those with an optimal incubation temperature close 
to 60Cْ, are termed thermophiles (Quinn et al., 2002).  
1.1.5 Pathogenicty:  
   Bacterial pathogens of insects has been used to control crop and forests pest 
for almost five decades. However, it has been used as an effective agent for its 
importance to public health, primarily in mosquitoes and blackfiles control 
(Tuason et al., 1979). Numerous Bacillus spp. have been identified as insect 
pathogens except Bacillus. Anthracis the causative agent of human and animal 
anthrax (Terrnova and Blake, 1978).  
Bacillus cereus was found associated with food poisoning and other 
opportunistic in human (Bergdoll, 1981). Other Bacillus species which may be 
viewed as potential opportunistic pathogens, include Bacillus sphericus 
Bacillus megaterium, Bacillus pumilus, Bacillus circulans, Bacillus 
licheniforms Bacillus, mycoides Bacillus macerans, Bacillus coagulans and 
Bacillus. thuringiensis (Sliman et al., 1987) . 
1.1.6Bacteriocin production                                                                 
Production of antimicrobial compounds seem to be a general 
phenomenon for most bacteria ( Sugita, 1998). An admirable array of 
microbial defense systems are produced, including broad-spectrum classical 
antibiotics, metabolic by-products such as organic acids, and lytic agents such 
as lysozyme. In addition, several types of protein exotoxins, and bacteriocins, 
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which are biologically active peptide moieties with bactericidal mode of 
action, were described (Sugita, 1998). This biological arsenal is remarkable in 
its diversity and natural abundance, since some substances are restricted to 
some bacterial groups while other are widespread produced (Riley and Wertz., 
2002).  
The search for new antimicrobial agents is a field of utmost importance. 
The prevalence of antimicrobial resistance among key microbial pathogens is 
increasing at an alarming rate worldwide (Singer et al., 2003). Current 
solutions involve development of a more rationale approach to antibiotic use 
and discover of new antimicrobials, but the problem of antibiotic resistance is 
increasing globally and may render the current antimicrobial agents 
insufficient to control at least for some bacterial infections (Bhavnani and 
Ballow, 2000). Many bacterial species produce peptide antibiotics, called 
bacteriocins, that   often   have an antimicrobial effect on closely related 
organisms (Naclerio et al 1993). These compounds have been extensively 
studied because of their potential applications in the food industry as natural 
biopreservatives and in pharmaceuticals as antimicrobials (Milles et,al 1992). 
Bacteriocins produced by lactic-acid bacteria have been the focus of many 
investigations because of their particular importance in the dairy industry 
(Jack et,al. 1995).  
1.1.7 Bacteriocins classification                                       
Based on their chemical structures, stability, and mode of action, 
bacteriocins have been classified as:(i) antibiotics (ii) small heat-stable 
peptides (iii) large heat-labile proteins and (iv) complex proteins that require 
carbohydrate or lipid moieties for activity (Klaenhammer ,1993). 
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1.1.8. Mechanisms of action  
The mechanisms of action of peptide antibiotics are diverse, but the 
bacterial membrane is the target for most bacteriocins (Klaenhammer ,1993). 
Sahl and Bierbaum, (1998) reported that antibiotics such as  nisin, subtilin and 
epidermin have novel secondary modes of action in addition to their well-
established lytic activity (Sahl and Bierbaum, 1998). This dual antibiotic 
activity of a single molecule no doubt plays an important role in the 
antimicrobial mechanism of some bacteriocins (McCafferty et,al .,1999). 
Several bacteriocins or bacteriocin-like molecules have been described for 
Bacillus spp., including coagulin (Hyronimus et., al 1998), cerein 7 (Oscariz 
et.al., 1999). Subtilosin   (Zheng and Slavik, 1999). And thuricin 7 (Cherif 
et.al 2001), and some of them have a broad spectrum of antibacterial activity. 
Bacillus cereus, isolated from soils of native woodlands of southern Brazil, 
has antagonistic action against several pathogenic and food-spoilage 
microorganisms, such as bacteria involved in bovine mastitis (Bizani and 
Brandelli, 2002). Treatment with proteases and trichloroacetic acid 
inhibits..Bacillus cereus antimicrobial activity (Bizani and Brandelli ,2002), 
suggesting that it produces a bacteriocin-like substance. 
Rodriguez et.al (2000) reported that Almost 70% of the isolates 
exhibited antimicrobial activity against one or more   indicator bacteria. 
Among lactic acid bacteria isolated from raw milk 82 of 298 strains (27.5%) 
displayed bacteriocin activity (Jaki et.al.,1999), while 8.7% of Staphylococcus 
aureus strains isolated from cattle produced antimicrobial substances (Oliveria 
et.al1998). (De Vuyst ,et.al.,2003) found that 122 of 426 Enterococcus strains 
(28.6%) of various origins produced enterocin. Antimicrobial evaluation of 
cyanobacteria demonstrated that 16.3% were active against Gram-positive and 
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5.8% against Gram-negative bacteria, while 10.5% possessed antifungal 
activity   (Jaki , et. al 1999). The high proportion of antimicrobial producing 
strains may be associated with an ecological role, playing a defensive action to 
maintain their niche, or enabling the invasion of a strain into an established 
microbial community (Riley and Wertz , 2002)  
The inhibitory effect was mostly against Gram-positive bacteria. Most 
strains inhibited Bacillus cereus(Riley and Wertz. , 2002). The antimicrobial 
spectra, essentially restricted to Gram-positive bacteria, may suggest that the 
produced antimicrobial substances are related to a specific feature of Gram-
positive bacteria. It is well known that activity of bacteriocins produced by 
Gram-positive bacteria is restricted to other Gram-positive bacteria (Riley and 
Wertz , 2002).  
Riley and Wertz  (2002)reported that The pH values of the crude 
antimicrobial substances indicate that the inhibitory effect was not due to 
production of organic acids. Most of these substances were partially or 
completely inactivated by proteases and TCA, suggesting that a protein 
moiety is involved in the activity. This may indicate that bacteriocin-like 
substances are implied in antimicrobial activity. These substances showed 
high thermal resistance and low molecular weight, which are characteristics of 
small hydrophobic peptides that constitute class II bacteriocins (Riley and 
Wertz,2002).  
A variety of antimicrobial compounds are produced by members of the 
genus Bacillus, many of these were identified as peptides, lipopeptides and 
phenolic derivatives (Nakano and Zuber, 1990). A wide range of antimicrobial 
substances produced by Bacillus spp. isolated from arthropods were recently 
described, including aromatic acids, acetylamino acids (amino acid analogs), 
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and peptides (Gebhardt et al,2002). Bacteriocin-like substances have been 
related from Bacillus spp. isolated from soil (Bizani and Bradelli ,2002) and 
vegetal tissues (Bechard, et al,1998). A siderophore with wide range of 
antibacterial spectrum is produced by Bacillus spp. from fish intestine (Sugita, 
1998) and aminopolyol antibiotic by soil isolates of Bacillus cereus (Stabb et 
al.,1994). 
 Bacteriocins are inhibitory peptides or proteins, produced by different 
groups of bacteria, which have bactericidal effects on micro-organisms closely 
related to the producer (Jack et al., 1995). They have received increasing 
interest, especially those produced by lactic acid bacteria (LAB), because of 
their potential use as food additives and their efficiency for the biological 
control of spoilage and pathogenic organisms (Delves-Broughton 1990). 
Klaenhammer (1993) reported that the using of nisin in processed 
cheese spreads has greatly stimulated research on the use of bacteriocins as 
antimicrobial agents in food systems in the USA. (Klaenhammer 1993). 
For the last decade, much research has focused on the bacteriocins 
produced by lactic acid bacteria (LAB) (Klaenhammer, 1993 and Jack et al. 
1995).  
Elsanousi and other In 1978 observed that the isolation of Closterdium 
chauvoei from Calves suspected to have died of blackleg disease was difficult. 
At the same time the frequent isolation of bacillus spp from specimens 
received from the field was suspected to have possible role played by bacillus 
ssp in inhibition of Clostridium chauvoei. The same authors tested the invetro 
inhibition of Clostridium chauvoei. Strain CH3by bacillus ceruse(Elsanoousi 
et al,1978).  
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1.1.9 Bacteriocinogenic species  
The genus Bacillus encompasses a number of bacteriocinogenic species 
such as Bacillus subtilis which produces subtilin  (Jansen and Hirschmann, 
1944) and subtilosin (Zheng and Slavik ,1999). Bacillus coagulans which 
produces coagulin (Hyronimus et al., 1998). Bacillus megaterium which 
produces megacin (Von Tersch and Carlton ,1983) . Unlike some bacteriocins 
produced by LAB, which can show a broad spectrum of activity against 
Gram-positive bacteria including non-bacteriocinogenic LAB strains, Bacillus 
spp. bacteriocins generally show a narrower inhibitory activity (Beegle and 
Yamamoto ,1992). 
Bacillus thuringiensis is widely used in agriculture for the control of 
many insect pathogens (Beegle and Yamamoto ,1992).  It is characterized by 
the production of crystal proteins (α-endotoxins) with a specific activity 
against certain insect species (Beegle and Yamamoto ,1992). Moreover, a 
number of extracellular compounds are produced by Bacillus thuringiensis, 
including phospholipases, chitinases, proteases (Lovgren et al. 1990) . 
β-exotoxins secreted vegetative insecticidal proteins and antibiotic 
compounds with antifungal activity (Stabb et al. 1994). The safe worldwide 
use of Bacillus  thuringiensis for over three decades on many agricultural 
crops for protection from several insect parasites argues strongly that the 
micro-organism can be harnessed for application in agriculture and industry 
for food and feed production (Drobniewski , 1993). 
Closely related to Bacillus thuringiensis are Bacillus cereus and 
Bacillus weihenstephanensis which are frequently involved in the 
contamination of food products such as boiled rice, raw milk and dairy 
products (Drobniewski, 1993).  The consumption of food contaminated with 
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Bacillus cereus can cause diseases associated with enterotoxins and emetic 
toxins (Drobniewski, 1993). Because of the close phenotypic and genotypic 
relation to Bacillus cereus and, Bacillus thuringiensis was considered to be a 
potential source of bacteriocins active against the two pathogenic species. 
Despite the wide biotechnological importance of Bacillus thuringiensis 
and its versatility as a biological control agent the selection of 
bacteriocinogenic strains has attracted little attention. Only four bacteriocins 
have been partially characterized from Bacillus thuringiensis/Bacillus cereus 
thuricin (950 kDa) and tochicin (10·5 kDa) from Bacillus thuringiensis strains 
HD2 and HD868, respectively (Favret and Yousten 1989, Paik et al. 1997); 
and cerein (9 kDa) and cerein 7 (3·9 kDa) from Bacillus cereus strains GN105 
and BC7, respectively (Naclerio et al. 1993) (Oscariz et al., 1999). 
1.2. Staphylococcus  
1.2.1. General characteristics:  
Staphylococcus are Gram-positive spherical bacteria that occur in microscopic 
clusters resembling grapes (Kenneth, 2002).  
The staphylococcus are divided into two groups on the basis of their ability to 
clot plasma (the coagulase reaction), the coagulase positive and coagulase 
negative staphylococcui (Kenneth, 2002). Nearly all strains of Staph aureus 
produce the enzyme coagulase and all strains of Staph epidermidis lack this 
enzyme (Kenneth, 2002). 
1.2.2 History, taxonomy and declassification of Staphylococcus: 
Staphylococci were observed in pus and cultivated by koch and Pasteur 
independently in 1878 and 1880, Ogston is credited with applying the name 
(Staphylococcus) in 1881 (Riemann, 1969).  
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In 1884 Rosenbach described the two pigmented colony types of 
Staphylococci and proposed the appropriate nomenclature: Staphylococcus 
aureus (yellow) and Staphylococcus albus (white).  
The latter species in now named Staphylococcus epidermidis (Kenneth, 2002).  
The genus staphylococcus is currently composed of 33 species, 17 of which 
may be encountered human clinical specimens (Koneman et al, 1997).  
As discussed before Staphylococci divided into two groups on the basisi of 
their ability to clot blood plasma by the action of Staphylococcui coagulase, 
the coagulase-positive species: Staph aureus, Staph intermedius and Staph 
delphini and the coagulase variable species Staph hyicus (Kloos, 1990). 
Coagulase negative species: Staph  epidermidis, Staph lugdunensis and Staph 
saprophyticus beside 30 more species (Kloos, 1990). 
 Staphylococci are generally found on the skin and mucous membranes of 
humans and other animals (Koneman et al., 1997). Staphylococi, which found 
in man and nonhuman primates are Staph aureus, Staph epidermidis, Staph 
saprophyticus, Staph haemolyticus, Staph warneri, Staph hominis, Staph 
simulans, Staph  lugdunensis, Staph  capitis, Staph  scheiferi, Staph pasteuri, 
Staph  auricularis, Staph  cohnii, Staph  xylosus, Staph saccharolyticus, Staph 
caprae, Staph pulvereri and staphylococci found in other animals are Staph 
gallinarum, Staph lentus, Staph equorum, Staph vitulus, and the other 
Staphylococcal species (mostly environmental) are Staph carnosus, Staph 
caseolyticus, Staph kloosii and Staph  arlettae  ( koneman et al, 1997 ).  Baron 
et al., (1994) reported that, Staph  lugdunensis, Staph  schleiferi, and Staph  
intermedius may also produce coagulase or clumping factor.  
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1.2.3 Morphology of staphylococci:  
Staphylococci are perfectly spherical cells about 1 micrometer in diameter 
they grow in clusters because staphylococci divide in two planes (Kenneth, 
2002). Although organism in clinical material may appear as a single cell, 
paris, or short chains (Murray et al., 1998). Young cocci stain strongly as 
Gram positive on aging many cells become Gram-negative (Brooks et al, 
1995).Capsules may be formed in very young cultures, but they disappear in a 
few hours (Riemann, 1969). 
1.2.4 Growth and cultural characteristics: 
Staphylococci grow readily on most bacteriological media under aerobic or 
micro aerophiliuc conditions (Brooks et al., 1995). They grow most rapidly at 
37Cْ but from pigment best at room temperature (20 – 25Cْ) (Brooks et al., 
1995). 
 The colonies, usually 1 – 3 mm in diameter, are smooth, circular, low convex, 
glistening, raised, and butyrous (Duguid, 1989).  
They are distinguished from those of most other bacteria by their golden or 
white pigmentation and greater opacity for their size (Duguid, 1989). 
 Staph aureus  usually from grey to deep golden yellow colonies (Brooks et 
al., 1995). Staph epidermidis colonies usually are grey to white on primary 
isolation many colonies develop pigments only upon prolonged incubation as 
he reported. No pigments produced anarobically or in broth (Brooks et al., 
1995). Various degrees of haemolysis are produced by Staph aureus and 
occasionally by other species (Brooks et al., 1995).  
Hemolytic patterns of species can be used in tracing back the source of 
infection (Devriese and Deryche, 1979). Staphylococci are aerobic and 
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faculatatively anaerobic, catalse-positive, non-motile, non-spore-forming, and 
fermentative (Carter et al., 1986). 
All Staphylococcus species are oxidase-negative except for strains of Staph 
caseolyticus, Staph sciuri, Staph lentus, and Staph vitulus (Koneman et al., 
1997). 
Under the influence of drug; like penicillin; staphylococci are lysed, also 
staphylococci slowly ferment many carbohydrates, producing lactic acid but 
not gas and proteolytic activity varies greatly from one strain to another 
(Brooks et al., 1995). 
 Pathogenic staphylococci produce many extraccelluar substances, some of 
these are toxic (Brooks et al., 1995). Many of the toxins are under both 
chromosomal and extra chromosomal control (brook et al., 1995). 
 Toxins are divided in to exotoxins, Leukocidin, Exfoliatuve toxin, Toxic shok 
syndrome toxin, and enterotoxins. The enterotoxins are heat stable (they resist 
boiling for 30 minutes) and resist the action of gut enzymes (Brokks et al., 
1995).  
Important causes of food poisoning, enterotoxins are produced when Staph 
aureus grow in carbohydrate and protein foods (Brooks et al., 1995). 
Staphylococci are initially recognized by the appearance of their characteristic 
colonies in a culture of Blood agar, Nutrient agar or MacConkey's agar 
(Duguid, 1989). Blod agar plates give rise to typical colonies in 18 hours at 
37Cْ (Brooks et al., 1995). They may form zones of heamolysis on blood agar 
(Duguid, 1989) . 
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Staphylococci can grow in a selective medium, which has a component added 
to it, inhibit and/or prevent the growth of certain types or species of bacteria or 
to promote the growth of the desired species (Kenneth, 1997). 
 Baird parker's medium is selective media which is mainly used for coagulase-
positive pathogenic staphylococci(Baird Parker,1962).On this medium 
coagulase-positive staphylococci growth is generally delayed (Saeed, 1995) 
and they reduce tellurite with production of black colonies (Jawetz et al., 
1980). Coagulase-negative species show delayed growth forming brownish 
black colonies (Saeed, 1995).  
Staphylococcus No. 110 medium is a selective and diagnostic medium which 
selects on the basis of salt tolerance. On this medium all strains of Staph 
aureus can grow (Chapman, 1946). Most of Staphylococci tested on this 
medium showed well growth (Saeed, 1995). 
 Mohammed (1997) found that Staphylococci varied in growth between weak 
moderate and failed to grow. Mannitol salt agar (M.S.A) is recommended for 
the detection and enumeration of staphylococcus species from food. Staph 
aureus yields colonies surrounded by a yellow hallo caused by the 
acidification of mannitol. Other Staphylococci may also ferment mannitol and 
thus resemble Staph aureus on M.S.A. (Baron et al., 1994).  
Staphylococci are relatively resistant to drying and heat. They withstand 50Cْ 
for 30 minutes (Brooks et al., 1995). Also they reported that a culture of 
staphylococci contains some bacteria that differ from the bulk of the 
population in expression of colony characteristics (colony size, pigment, 
haemolysis), in enzyme elaboration, in drug resistance, and in pathogencity. 
Under standard conditions all Staphylococci are V.P. positive except Staph 
intermedius, Staph hyicus and Staph Simulans. 
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1.2.5. Staphylococcus infection:  
Staphylococci generally are found on the skin and mucous membranes of 
humans and other animals (Koneman et al., 1997).  
Many species of Staphylococci are opportunitistic pathogens that cause 
infection when host defenses breakdown (Baron et al., 1994). Staphylococcus 
is an important pathogen in human that can cause a wide spectrum of diseases, 
including life threatening system maladies, cutaneous infections, opportunistic 
infections, and urinary tract disease (Muttay et al., 1998).  
Staphylococci among the most frequently isolated organisms in the clinical 
laboratory (Koneman et al, 1997).  
Staphylococcus aureus should always be considered a potential pathogen 
(Kenneth, 2002). Staph epidermidis are non pathogenic and may even play a 
protective role in their hosts as a normal flora, but may be pathogen in the 
hospital environment (Kenneth, 2002).  
No vaccine is available to that stimulates active immunity against 
Staphylococcal infection in humans (Kenneth, 2002).  
The coagulase negative Staphylococci are normal human flora and some 
time cause infection, often associated with implanted appliances and devices, 
specially in very young, old, and immuno-compromised persons (Brooks et al, 
1995). Approximately 75% of these infections caused by coagulase-negative 
staphylococci are due to Staph.  
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1.2.6 Staphylococcus  aureus 
Staphylococcus aureus is one of the major causes of hospital-acquired 
infection (Kenneth,1998). One study ranked it fourth in a listing of the 
“Pathogens Most Frequently Isolated from hospitalized patients when all 
anatomic sites are considered (Kenneth, 1998).  
 Approximately 40% of the general population and 50 – 90% of health 
care practitioners harbor an Staphylococcus aureus colony in their anterior 
nasal passage.  Infection becomes a problem when bacteria migrate from their 
normal habitat, especially in individuals already suffering from a 
compromised immunologic response. (Kenneth,1998) 
 Staphylococcus aureus most commonly causes a localized skin 
infection, although it can also infect the eye, nose, throat, urethra, vagina, and 
gastrointestinal tract (Kenneth,1998). 
  In addition, Staphylococcus aureus can cause more serious disease 
when it enters the bloodstream, such as pneumonia, osteomyelitis, arthritis 
endocarditis, myocarditis, brain abscesses and meningitis (Kenneth,1998). 
The toxins most relevant to disease causing symptoms in humans are 
the superantigens and α-toxins(Kenneth,1998).  
The α-toxins oligomerize to form pores in the host cellular membrane, 
allowing cellular contents to leak into the extracellular matrix. 
(Kenneth,1998)  The superantigens, consisting of enterotoxins and the toxic 
shock syndrome toxin, are responsible for Staphylococcus aureus-related 
food poisoning and toxic shock syndrome, respectively.   Individuals with 
damaged or severely compromised immune systems, such as recent surgical 
recoveries or burn victims, IV drug users, insulin-dependent diabetics and 
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hemodialysis patients are more susceptible to Staphylococcus infection than 
healthy individuals(Kenneth,1998).   
 Individuals identified with Staphylococcus infections are most 
commonly found in hospital intensive care units, burn units, and dermatology 
and surgical units, reflecting the increased susceptibility of these individuals 
to Staphylococcus infections due to compromised immune function.  
Treatment of  Staphylococcus aureus infections showing no signs of broad-
antibiotic resistance is achieved with a cocktail of antibiotics, including some 
of the following: gentamycin, rifamicin, fusidic acid, erythromycin, 
vancomyin, and cefotaxime.  However, 90% of Staphylococcus aureus strains 
are penicillin resistant.  In these scenarios, methicillin and vancomycin are 
the only available treatment options(Kenneth,1998). 
1.2.7 Staphylococcos  epidermidis  
Staphylococcus epidermidis is a coagulase-negative bacteria (Coppoc, 
1996). Like Staphylococcus  aureus, Staphylococcus epidermidis is a common 
cause of nosocomial infections, particularly blood infections which can lead to 
complications of the central nervous system. (Coppoc, 1996).  
 Staphylococcus epidermidis resides primarily in the skin, leaving those 
who have frequent contact with needles and other invasive health care 
appliances particularly susceptible to illness Staphylococcus epidermidis is 
very likely to contaminate patient-care equipment and environmental surfaces, 
possibly explaining the high incidence of Staphylococcus epidermidis in 
hospital settings.  
 While there is extensive information concerning Staphylococcus 
aureus virulence factors, there is relatively little known about Staphylococcus 
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epidermidis mode of action  Infection is treated primarily with vancomycin or 
rifampin (Coppoc,1996). 
1.2.8 S Staphylococcus  saprophyticus  
Staphylococcus saprophyticus is a common cause of urinary tract 
infections in men and women.  Risk factors and treatment guidelines are the 
same as those described for Staphylococcus aureus (Coppoc,1996) 
1.2.9 A closer Look at Vancomycin Resistance  
Staphylococcus aureus strains acquired in the hospital are often 
resistant to many types of antibiotics (Bogle, 1997) . A significant portion of 
Staphylococcus aureus strains are now methicillin-resistant, in addition to 
being resistant to other penicillin-derived drugs (Bogle,1997)  . For these 
methicillin-resistant strains, vancomycin is the only available, effective drug 
for treatment (Bogle, 1997) .  However, in 1996, there were reports of strains 
of Staphylococcus aureus with decreased susceptibility to vancomycin, 
labelled glycopeptide intermediate-resistant Staphylococcus aureus, or 
vancomycin-intermediate Staphylococcus aureus (GISA and VISA, 
respectively). (Bogle, 1997).   In the early 1990s, vancomycin-resistant 
enterococci (VRE) emerged.  Laboratory tests have shown that resistance, 
coded in the VanA, VanB and VanC genes, can be transferred from 
Enterococci to Staphylococcus and other Gram-positive bacteria. For such 
transfer to occur in a non-laboratory controlled environment, there would be 
no FDA-approved, effective means of combating multi-drug resistant 
Staphylococcus infections (Bogle,1997) . 
Staphylococcus aureus can acquire resistance through 
extrachromosomal plasmids , through additional genetic information delivered 
by transposons, and through mutations in chromosomal genes.  Resistance is 
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achieved through a variety of mechanisms, including enzymatic inactivation 
of the drug (as with penicillinase , which cleaves the beta-lactam ring of 
penicillins), alteration of the drug target to prevent binding, and enhanced 
removal of the drug from the host tissue (Bogle, 1997) . 
A mutation in the MecA gene of Staphylococcus will provide resistance 
to all beta-lactams (Bogle, 1997) .  This gene codes for Penicillin Binding 
Protein  a mutation in the gene prevents penicillin from effectively binding 
foreign particles. Exposing a bacterial culture to oxacillin tests resistance to 
beta-lactams.  If the bacteria is resistant to oxacillin, it will be resistant to all 
beta-lactams, and quite possibly also resistant to erythromycin, gentamicin, 
tetracycline, and clindamycin (Bogle, 1997). 
Vancomycin resistance has been, to date, documented in enterococci, 
but not in staphylococcus (Bogle, 1997).   Enterococci are Gram positive 
pathogens, listed as the second most common cause of hospital-acquired 
bacterial infections.  They are part of the normal bacterial-makeup of the 
human gastrointestinal tract, and like Staphylococci, cause infection when 
they enter the bloodstream.  Enterococci can cause urinary tract infections, 
wound infections, septicaemia and endocarditis.  They are naturally resistant 
to cephalosporins, aminoglycosides and clindamycin, but were, until recently, 
susceptible to vancomycin.  The vanA and vanB genes are responsible for 
encoding vancomycin resistance in the majority of Enterococci infections.  
Enterococci are transmitted via person-to-person contact (i.e. on the hands of a 
health care provider), or through indirect contact (i.e. through contaminated 
environmental surfaces).  The vanA and vanB genes are responsible for 
resistance transmittance vanC is a chromosomal gene that cannot be 
transmitted between Gram-positive organisms (Bogle, 1997). 
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1.3 Antimicrobial Chemotherapy  
Antimicrobial drugs exploit differences in structure or biochemical function 
between host and parasite (Zee and Hirsh, 1999 ) . 
 Modern chemotherapy is traced to the work of Paul Ehrich, who devoted his 
life to discovering agents that possessed selective toxicity (Zee and 
Hirsh1999) 
The first clinically successful broad-spectrum antibacterial drugs were the 
sulfonamides, developed in 1935 as a result of Ehrlich's work with synthetic 
dyes. It was, however, the discovery of further antibiotics, led to the 
subsequent discovery of further antibiotics, chemical substances produced by 
microorganisms that at low concentrations inhibit or kill other microorganisms 
(Zee and Hirsh, 1999 ). 
The chemical modification of many of the drugs discovered early in the 
antibiotic revolution has led to the development of new and powerful 
antimicrobial drugs with properties distinct from their parents. 
 Antibiotics and their derivatives have more importance as antimicrobial 
agents than do the fewer synthetic antibacterial drugs (Zee and Hirsh1999 ).  
1.3.1 Spectrum of action of antimicrobial Drugs 
Antimicrobial drugs can be classified as narrow or broad spectrum based on 
the range of bacteria on which they act  (Zee and Hirsh, 1999).  
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1.3.1.1Classification of microorganism 
Penicillin is narrow spectrum because they inhibit only Gram positive 
bacteria. Choramphramphenicol are broad spectrum because they inhibit both 
Gram poitive and gram Negative bacteria. Polyenes only inhibit fungi (Zee 
and Hirsh ,1999 
1.3.1.2Antibacterial activity  
Some antibiotics are narrow spectrum in that they inhibit only Gram –positive 
bacitracin (Vancomycin) or Gram negative bacteria (polymyxin) whereas 
broad spectrum drugs such as tetracyclines inhibit both Gram positive and 
Gram negative bacteria. Other drugs such as penicillin G are most active 
against Gram –positive bacteria but will inhibit some Gram –negatives (Zee 
and Hirsh, 1999).     
1.3.1.3 Bacteriostaic and bactericidal effect of antimicrobial  
. This distinction is an approximation that depends on drug concentrations and 
the organism involved. For example, penicillin is bactericidal at high 
concentrations and bacteriostatic at lower ones. (Zee and Hirsh, 1999).  
 The distinction between bactericidal and bacteriostatic is critical in certain 
circumstances, such as the treatment of meningitis or septicemia in 
neutropenic patients (Zee and Hirsh, 1999). 
1.3.2Mechanism of action of antimicrobial drugs:  
The marked structural and biochemical differences between eukaryotic and 
prokaryotic cells give greater opportunity for selective toxicity of antibacterial 
drugs compared to antifungal drugs because fungi, like mammalian cells, are 
eukaryotic. Developing selectively toxic antiviral drugs is particularly difficult 
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because viral replication depends largely on the metabolic pathways of the 
host cell (Zee and Hirsh, 1999).  
The mechanism of action of antibacterial drugs fall into four categories: 1) 
inhibition of cell wall synthesis, 2) damage to cell membrane function, 3) 
inhibition of nucleic acid synthesis or function, and 4) inhibition of protein 
synthesis (Zee and Hirsh, 1999).  
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CHAPTER TOW 
MATERIALS AND METHODS 
 
2.1 Organisms 
  Thirty two isolate of Gram-positive bacilli were screened for their 
antibiotic-like production .They were isolated from contaminated cultures. 
The isolates were cultured in blood agar for purification and stored in cooked 
meat media at 4Cْ. Identification was based on morphology staining and 
biochemical characters following Barrow and Feltham (1993) and (Sneaths et 
al.1986). 
2.2 Equipments 
   The equipment used for isolation, storage, identification of different 
sample of bacillus and Staphylococcus are: 
Slides, wire loop  (standard loop with 4mm internal diameter, oil of 
immersion for lenses (Hopkin William, England) graduate pipettes  of 
different size (Pyrex,    England ) Pasteur pipettes , wooden and metal racks , 
media Bottles of different sizes bijou , McCartney , universal and large sizes 
disposable Petri dishes (  Sterling ltd. England ) glass  Petri dishes ( Pyrex 
England) syringes , 20 ml , 1ml  , Haste, Italy ) filter paper 1.25 cm  (England  
graduated glass cylinder of different size , conical flat bottles (Pyrex , 
England) , round flask (Pyrex , England )  Durham’s tubes membrane  filter 
0.22Mic                                                                         
Microscope (Olympus, Tokyo, Japan) pH-meter (corning model 10) 
Thermostatically controlled incubator 37˚C,Admiral refrigerator, Autoclave 
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(Baird and Tatlock ltd. London, England),Centrifuge, Millipore Filter holder 
(Millipore filter corp. Bedford Mass. U.S.A)  
2.3 Media  
 Media used for cultivation and identification of Bacillus Spp. and 
Staphylococcus spp  
2.3.1Nutrient broth(Oxoid) 
The medium was prepared by dissolving 13g of the medium in one liter 
of distilled water .The pH was adjusted to 7.4  and distributed into screw-
capped boottles 5ml each and sterilized at 121°C for 15 minutes 
2.3.2 Nutrient agar(Oxoid)  
The medium was prepared by dissolving 28grams of powder in one liter 
of distilled water by boiling .The medium was sterilized by autoclaving 
(121°C for 15 minutes, cooled to 55°C and then distributed into sterile Petri 
dishes 20 ml in each 
2.3.3Blood agar(Oxoid) 
Forty grams of blood agar base  (Oxoid )were suspended in liter of distilled 
water , steamed to dissolved ,cooled and the PH adjusted to 7.4 , it was then 
sterilized by autoclaving at 121°C for 15 minutes  after cooling to about 45°C 
, defibrinated sheep blood was added aseptically in 7-10٪  concentration 
before pouring into plates in 15 ml amounts 
2.3.4Indole Medium(Oxoid)  
The indol medium was prepared   according to Barrow and Feltham 
(1993)from the following (G/L, W/V) Bacto peptone (Oxoid), 20g, sodium 
chloride (B.D.H), 5g and D.W 1000 ml. The tested microorganisms were 
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inculcated in peptone water then incubated at 37°C for 48 hours. Three drops 
of kovacs reagent were added to culture and shaken well. Production of pink 
co lour on upper layer of the reagent was considered indol positive  
2.3.5 Voges -Proskauer test (V P) 
V P medium was prepared according to Barrow and Feltham (1993) as 
follows :( G/L, W/V), peptone 10g, glucose 5g, distilled water1000 ml. 
This test was performed to detect the production of acetylmethyl carbinol . 
Glucose phosphate broth was inoculated with tested organisms and incubated 
at 37 ْC for 48 hours, then O.6 ml of alpha-naphthol solution followed by 0.2 
ml of40% potassium hydroxide solution were added to one ml of culture, 
mixed well and examined after 15 minutes and one hour .Bright red colour 
indicated positive result 
 2.3.6Casein agar (milk agar) medium(Oxoid) 
Prepared according to Barrow and Feltham (1993) as follows :whole 
fresh milk was stored overnight in refrigerator .The creamy layered was 
removed ,and the milk was steamed for one hour and cooled in refrigerator 
.Sufficient litmus solution was added to give a bluish –purple colour and the 
medium was sterilized at 115°C for 10 minutes .It was then cooled to about 50 ْ
C and added to double strength nutrient agar which was melted and cooled to 
50-55°C, mixed and distributed in Petri-dishes .Casein agar plate was 
inculated with tesed cultured and incubated at 37°C for 24-48 hour for 
clearing the medium around the bacterial growth    
2.3.7Starch medium  
Starch medium was prepared according to Barrow and feltham (1993) 
as follows: Fifty grams of starch were triurated with water to smooth cream 
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.And then added to molten  nutrient agar .The mixture was sterilized at 115° C 
for 15 minutes and distributed into sterilized Petri dishes 20ml in each .Starch 
agar plate was inoculated with tested culture and incubated at 37°C  for 
24hour .Plate flooded with lugol”s iodine solution  .Hydrolysis was indicated 
by clear co lour less zones .Starch which had not been hydrolyzed turned blue  
  
2.3.8Gelatin agar medium (Oxoid) 
Gelatin agar medium was prepared according to Barrow and Feltham 
(1993) as follows: 
Gelatin 4g, D.W.50ml, nutrient agar 1000 ml the gelatin was soaked in the 
water and when thoroughly softened was added to melted nutrient agar .mixed 
and sterilized at 115°C for 10 min. 
2.3.9 Citrate medium (Oxoid) 
Twenty three grams of powder were dissolved in to 1000 ml distilled 
water by boiling. The pH was adjusred to 7.0, and then the medium was 
sterilized by autoclaving at 121°C for 15 minutes and distributed in to sterile 
Scrow –caped bottle and allowed to solidify in slope position.The citrate 
medium was inculated with tested organisms, incubated at 37°C and examined 
daily for up to seven days .The devoloment of blue colour in the medium was 
consider positive result   
2.3.10 Ammonium salt sugar(Oxoid) 
Ammonium salt sugar was prepared according to Barrow and Feltham 
(1993) as follows: 
This medium consisted of ammonium phosphate chloride magnesium 
sulphate, Yeast extract agar and bromcresol purple .It was prepared by adding 
 29
the solids to 1000ml distilled water, dissolved completely by boiling and 
sterilized at 115°C for 20 minutes .The medium was allowed to cool to about 
55°Cand the appropriate sugar was added as sterile solution to give a final 
concentration 1% the medium mixed and distributed aseptically in to sterile 
tubes, then allowed to set in slope position   
2.3.11Motility medium (Oxoid) 
Thirteen grams of dehydrated nutrient broth were added to 4grams of 
agar and dissolved in one liter of distilled water by boiling and the pH was 
adjusted to 7.4, distributed in 5ml amounts in tests tubes containing craig-
tubes and sterilized by autoclaving at 121°Cfor 15 minutes. The carigie tube 
was used to detect the motility of the organisms. The growth of the 
microorganism outside the tube indicated that it is motile organisms 
2.3.12Hugh and Leifsons (O\F) medium (Oxoid) 
The medium was prepared by dissolving 10.3grams of solid in liter of 
distilled water by heating ,and the pH adjusted to 7.1 .Filtered bromothymol 
blue (.2%aqueous solution) was added and then sterilized at 115°C for 20 
minutes .Sterile solution of glucose was added aseptically in to sterile tubes. 
Two tubes of Hugh and Leifson’s medium were inoculated with tested 
organism. One of them was covered with a layer of sterile paraffin, all tubes 
were incubated at 37°C and examined daily for seven days .Fermentative 
organisms produced a yellow color on both tubes while oxidative organisms 
produced a yellow colour only on open tube 
2.3.13 Nitrate Broth (Oxoid) 
One gram of nitrate was dissolved in one liter of nutrient broth ,then 
distributed in to tubes and sterilized by autoclaving at 115°C for 15 minute 
 30
.The tested microorganism was grown in nitrate broth and incubated at 37°C 
for 5 days .one ml of nitrate reagent A was added followed by one ml of 
reagent .A deep red color produced was considered as positive reaction .Tubes 
that did not show red color ,zinc powder was added and followed to stand 
.Formation  of red color indicate that nitrate was present and that tested 
organism did not reduce it           
2.4. Buffers 
2.4.1 Normal Saline  
Normal saline was prepared as described by Barrow and Feltham 
(1993) from the following (G/L ,  W/V) sodium chloride (B.D.H) 8.5g, 
distilled water one liter .the salt was dissolved in distilled water ,the mixer was 
then distributed in bottles of different sizes ,autoclaved at 121°C for 20 min. 
and store at room temperature for later use 
2.4.2 Distilled Water  
Tap water was distilled using distillator (Elga England) 
2.5 Test reagents 
2.5.1 Hydrogen peroxide 
The reagent was prepared as described by Barrow and Feltham (1993) 
from hydrogen peroxide (H) (Analar) 3% aqueous solution (10 volumes). 
2.5.2 Nitrate test reagents 
The reagents were prepared as described by Barrow and Feltham (1993) 
solution A sulphanilic acid 33%in 5N- acetic acid, dissolved by gentle heat  
solution B: Dimethyl -naphthylamin 0.6%in 5N-acetic acid  .The complete 
reagent was used to detect nitrate reduction . 
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2.5.3 Neutral red Reagent 
The reagent was prepared according to Barrow and Feltham (1993) as 
follow :from neutral red (B.D.H) 1g and D.W. 100ml .the reagent was 
prepared by dissolving 1g of neutral red in 100 ml D.W .to form o.1% solution 
. The indicator was autoclaved at 121° C for 15 minutes and kept at 4°C. 
 
2.5.4 Kovac’s reagent 
The reagent was prepared as described by Barrow and Feltham (1993) 
this reagent of paradimethyl- aminobenzaldehyde, amylalcohol and 
concentrated hydrochloric acid .after preparation the reagent was steored in 
the refrigerator at 4°C.   
2.5.5 Methyl red  
The indicator was prepared according to Barrow and Feltham (1993) 
from the following :Methyl red (B.D.H),1g ethanol (analar) ,300ml and 
D.W.200ml the ingredients were mixed and kept at 4°c  
2.5.6 Bromocresol purple  
 The reagent was prepared as described by Barrow and Feltham (1993) 
Bromocresol purple solution was prepared as 0.9% solution. It was used in 
ammonium salt sugar 
2.5.7 Polyethylene glycol  
Ready –made Flakes were obtained commercially (B.D.H) 
2.5.8 Xylene 
Ready –made solution was obtained commercially (B.D.H) 
 
 32
2.5.9Sodium chloride 
In solution (NaOH) (B.D.H) was prepared by dissolving 40g of powder 
in one litre D.W to form NAOH solution  
2.5.10 Hydrochloric acid  
Hydrochloric acid solution was prepared by dissolving 36.5 ml 
concentration Hydrochloric acid in one litre D.W 
2.5.11 Oxidase test reagent 
This was prepared as 1%tetramethyl-p-phenylene diamine 
dihydrochloride aqueous solution it was kept at 4°c in stoppered glass bottle 
and was protected from light.  
2.5.12 Andrads indicator  
The indicator was prepared as described by Barrow and Feltham 
(1993).This was prepared by dissolving 5g of acid fuchsin in one liter of 
distilled water ,then 150ml of alkali solution (NaOH).It was used in peptone 
sugar medium  
 2.6 stains 
 2.6.1 Gram Stain 
Standerd stains as described by Barrow and Feltham (1993)  were used  
2.7 Selection of Bacillus spp which produce active metabolite 
  Fresh cultures of Staphylococcus grown in nutrient broth were sown 
on the surface of nutrient agar. The plates were left to dry. A drop of Bacillus 
SPP cultures was applied on the surface of the sown agar, left to dry and 
incubated at 37°C over nigh t.This criteria will lead to select Bacillus Spp 
which produce metabolite that can inhibit Staphylococcus. 
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2.7. Preparation of metabolite  
Nutrient broth was cultured with fresh Bacillus spp and incubated for 
8hours at37 ْ C then the culture was centrifuged and the supernatant was 
removed aseptically and placed in dialysis tube in poly ethylene glycol in 
order to concentrate the metabolite .The supernatant was then filtered with 
0.22Mm filter and kept in sterile tubes and stored at 4°C. 
2.8. Methods for detection of the inhibitory effect of Bacillus SPP. 
metabolite on Staphylococcus  
 2.8.1The Disc method  
      Staphylococcus spp. were cultured in nutrient agar plate using wire loop 
(Streaking ) . Filter paper discs were prepared in the lab by soaking them in 
the filtrates of 3 bacilli metabolite .then they were placed on nutrient agar 
surface in similar manner to antibiotic sensitivity discs. Figure (1) 
(Personal method .Professor Suliman M. Elsanousi) 
2.8.2 Scraping   method  
Fresh cultures of Bacillus spp were  grown as blob inoculation method in 
nutrient agar .They  were then incubated at 37°C for an over night. The growth 
was scraped off using bent sterile glass rod . A few drops of chloroform were 
spreaded all over the plate .The plate were allowed to dry. Staphylococcus spp 
were cultured in a perpendicular manner across the place on which Bacillus 
spp were grown .The plates were incubated at 37°C for an overnight to study 
the inhibitory effect of the metabolites secreted by Bacillus spp on 
Staphylococcus. (Personal method .Professor Suliman M. Elsanousi) 
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2.8.3 Strip method  
Fresh cultures of Staphylococcus in nutrient broth incubated for 24 hours were 
spreaded on surface of nutrient agar, Then a strip filter paper soaked in the 
filtrates of bacilli metabolite was placed on nutrient agar surface and the plates 
were incubated at 37°C for overnight. Figure (2) (personal method .Proffessor 
Suliman M. Elsanousi) 
2.9 Determination of inhibitory activity unit (IAU) of metabolite in 
filtrates 
The filtrates were sequentially diluted with normal saline 5 times. Eeach 
of these dilution was tested against Staphylococcus spp, in order to establish 
the minimum inhibitory concentration of the metabolite against 
Staphylococcus .One (IAU)was defined as higher dilution of filtrates that 
inhibits in vitro the growth  of target pathogen .Table (1) 
2.10 Determination the bacteriostatic and bactericidal activity of 
antibiotic metabolite in filtrates  
From the inhibitory zones of Staphylococcus, Swabs were taken from surface 
of the agar where no Staphylococcus growth was observed   , then the swabs 
were cultured on agar surface and incubated for 48hours in 37°C . Growth or 
no growth, made differences between bacteriostatic and bactericidal  activity   
of filtrates. (Personal method .Professor Suliman M. Elsanousi) 
2.11 Thermostability  
1.5 ml of filtrates was dispensed in Eppendorf  sterile tubes .The tubes 
were treated as follows 1) maintained at room temperature 25ºC 2) water bath 
heated at 100°C during 15 min and 3) autoclaved at 121°C during 20 min 
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.from each set of tubes, 0.5 ml were tested against staphylococcus for 
inhibitory activity as shown in Table (2) 
2.12 Solubility in methanol of metabolite in filtrates 
One volume of antibiotic metabolite filtrate mixed with one volume of 
methanol 
2.13 Stability of metabolite against enzymes 
One ml of metabolites filtrate were placed in   two tubes, one tube was 
treated with proteinase K, and the other one with trypsin and incubated at 
37°C for two hours, to let enzyme work, then the enzymes were inactivated by 
heating at 60°C, before they tested against Staphylococcus as shown in 
Table(3)                       
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CHAPTER THREE 
RESULT 
 
3.1 Thirty two isolates of Gram positive  bacilli were screened for their 
production of metabolites against Staphylococci. 
 Three of them were positive for production of metabolites active against 
Staphylococci.(Their metabolite completely inhibited the Staphylococcus 
growth in vitro )They were Bacillus cereus ,Bacillus licheniformis and 
Bacillus subtilis  
The Staphylococcus spp. which were sensitive to these metabolites produced 
by Bacillus were Staphylococcus aureus, Staphylococcus epidermidis and 
Staphylococcus saprophyticus                                               
3.2 Determination of inhibitory activity unit (IAU)   of metabolite in 
 filtrates 
Different metabolite dilutions were tested against Staphylococcus spp in 
order to determine the inhibitory activity unit which is higher dilution of 
metabolite filtrate that inhibits in vitro the growth of Staphylococcus as shown 
in Table (1) 
The inhibitory activity unit which is higher dilution of metabolite 
filtrate that inhibits in vitro the growth of Staphylococcus was 1x10-1 
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Table (1) 
Determination of inhibitory activity unit (IAU) of 
metabolite in filtrates 
 
Size of inhibition zone (cm) Dilution factor 
0.5 1x10-1 
0 1x10-2 
0 1x10-3 
0 1x10-4 
0 1x10-5 
 
3.4 Determination the bacteriostatic and bactericidal activity of 
metabolite in filtrates 
No growth was observed in nutrient agar surface that mean: 
The metabolite has bactericidal effect against some Staphylococcus spp. 
3.5Thermostability 
The metabolite filtrates were treated with three different temperatures 
(Room temperature 25°C, 37°C-100°C water bath and autoclaving 121°C ) 
giving the following result .The result showing that the metabolites were 
unstable in high temperatures (Heat sensitive) as shown in table (2) 
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Table (2) 
Thermostability of metabolite after treated by different temperatures  
 
Diameter of inhibition zone (cm) Treatments 
1.5 Room temperature (25 ْ C ±2 ْ C)  
20 minutes  
0.5 Water bath (100 ْ C ±2 ْ C) 20 minutes 
0 Autoclaving (121 ْC±1 ْ C) 20 minutes
 
3.6 Solubility of active metabolite filtrates in methanol  
The metabolites were soluble in methanol 
3.7Stability of the active metabolite against enzymes 
To establish stability of the active metabolite against enzymes ,the 
metabolites were treated with protienase K and Trypsin enzyme .The 
metabolites were denatured with protieanse K and no effect was detected with 
Trypsin Enzyme. (Table 3) 
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Table( 3 ) 
Stability of the active metabolite against enzymes 
 
 
 
 
 
 
 
The detection of the inhibitory effect of Bacillus subtilis metabolites on 
Staphylococcus epidermidis is shown in fig( 1) 
 
Inhibition zone size (cm) Enzyme 
0 Protienase K 
1.5 Trypsin 
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Figure (1) 
Demonstration of the inhibitory effect of Bacillus subtilis. metabolite on 
Staphylococcus epidermidis (The Disc method) 
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Figure (2) 
Methods for detection of the inhibitory effect of Bacillus subtilis. 
Metabolite on Staphylococcus epidermidis 
Strip method 
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Figure no (3) 
 
detection of the inhibitory effect of Bacillus cerues. Metabolite on 
Staphylococcus aureus 
The Disc method 
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CHAPTER FOUR 
DISCUSSION 
 
This study has dealt in its object with three aspects .The first one was 
the   isolation and identification of different species of the genus Bacillus that 
might produce a metabolite which has inhibitory effect  on Staphylococcus 
spp .The second one was the study of the inhibitory effect of these Bacilli and 
their products on staphylococcus spp. The third one was to study the physical 
and chemical properties of these metabolites. 
 Synthesis of peptide antibiotic usually starts at the end of exponential 
growth reaching maximum concentration after cell growth has ceased 
(Bodanszky and Perlman ,1969) The factor triggering the onset of antibiotic 
synthesis is more likely the exhaustion of limiting nutrient required for cell 
growth. This limitation usually stimulates differentiation which for the case of 
Bacilli, means endospore  formation. Sporulation is associated with synthesis 
of new cell wall and degradation of that in mother cell .This cell wall like 
antibiotics contains D-aminoacids. It is suggested that an altered metabolism 
for cell wall synthesis could furnish the precursors for antibiotic 
synthesis(Besson et al, 1987)                                                                                      
Bioassay based on clearing zone on agar plate was used to determine 
the bactercidial activity of metabolite produced by Bacillus spp against 
Staphylococcus. Inhibition zone revealed the production of strong antagonist 
by Bacillus spp. These results are interesting, because the antibiotic produced 
inhibit the growth of both prokaryotes and eukaryotes ,as in case of other  
antibiotic synthesis by Bacillus subtilis (Maget –Dana and Pypoux, 1994).                    
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According to our result the antibiotic produced by Bacillus spp has 
bactericidal and probably fungicidal activity .The target site for iturin A and 
bacillomycin L antibiotic produced by Bacillus subtilis in yeast is in plasma 
membrane. Both antibiotics promote sphreroplast and rapidly increase 
permeability to K+ which has been   associated with its fungicidal   activity  
(Besson et al. 1984). The ability of iturin antibiotic to increase permeability of 
target microorganism is due to the formation of ion channels on cell 
membrane. In this context a tertiary structure iturin –phospholipid –sterol was 
suggested to be the biologically efficient   structure (Maget_Dana and 
peypoux, 1994). 
Balassa  (1964) reported that there is direct correlation between 
sporulation and production of some exoenzyme , antibiotic and exotoxin .  
It was already known in 1949 that bacilli produce many antibiotics 
(Abraham and Florey., 1949 ) . At least some of these antibiotics are species 
specific and one of species may produce several ones . Bacillus subtilis is 
agood example in addition to antibacterial antibiotics  (Abraham and Florey., 
1949 ). 
No attempt was made here to review the problem of the mode action of 
these antibiotics on sensitive bacteria , beyond saying that many cell function 
are affected by one or another ,cell wall synthesis ,oxidative phosphorylation 
,membrane permeability (Bernolohr and Novelli,1959)  
Bernolohr and Novelli (1959 ) reported that in the case of bacteriocin 
produce by Bacillus licheniformis antibiotic molecule is subunit of spore coat 
protein is incorporated as such in the late stage of spore formation.  
We recommend the search for more bacteriocin – producers bacilli and 
their effect on various type of bacteria   
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